Chemotherapy News and Research

Latest Chemotherapy News and Research

Inotuzumab ozogamicin study reveals complete remission rates higher than standard therapy for ALL patients

Inotuzumab ozogamicin study reveals complete remission rates higher than standard therapy for ALL patients

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

OTC remains best option to preserve fertility of prepubertal girls treated with gonadotoxic chemotherapy

OTC remains best option to preserve fertility of prepubertal girls treated with gonadotoxic chemotherapy

Intrinsic subtyping of breast cancer can aid prognosis, treatment of tumor patients

Intrinsic subtyping of breast cancer can aid prognosis, treatment of tumor patients

Tackling Healthcare Challenges in a Changing World: an Interview with Professor Jeremy Nicholson

Tackling Healthcare Challenges in a Changing World: an Interview with Professor Jeremy Nicholson

Scientists discover new ZBTB7A gene mutation that promotes growth of cancer cells

Scientists discover new ZBTB7A gene mutation that promotes growth of cancer cells

Pre-procedure medication regimen could lower incidence of hospital readmission in lung caner patients

Pre-procedure medication regimen could lower incidence of hospital readmission in lung caner patients

Surgery improves survival in late-stage NSCLC patients

Surgery improves survival in late-stage NSCLC patients

Whole-exome sequencing can help characterize genetic alterations for commonly used bladder cancer cell lines

Whole-exome sequencing can help characterize genetic alterations for commonly used bladder cancer cell lines

Drug candidate delivered by plant-virus-based carrier shows promise for triple-negative breast cancer

Drug candidate delivered by plant-virus-based carrier shows promise for triple-negative breast cancer

NMR-based metabolomics: an interview with Prof. Claudio Luchinat

NMR-based metabolomics: an interview with Prof. Claudio Luchinat

Researchers identify promising new compound for targeting triple-negative breast cancer

Researchers identify promising new compound for targeting triple-negative breast cancer

Mathematical approach can help achieve optimal dosing for various drugs

Mathematical approach can help achieve optimal dosing for various drugs

New drug-capture device can soak up chemotherapy drugs to limit toxicity

New drug-capture device can soak up chemotherapy drugs to limit toxicity

NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

Researchers find link between obesity and disease relapse in pediatric Hodgkin lymphoma patients

Researchers find link between obesity and disease relapse in pediatric Hodgkin lymphoma patients

Two autologous stem-cell transplants improve survival of children with high-risk neuroblastoma

Two autologous stem-cell transplants improve survival of children with high-risk neuroblastoma

Scientists develop non-toxic transplantation procedure using antibodies to target blood stem cells in mice

Scientists develop non-toxic transplantation procedure using antibodies to target blood stem cells in mice

Study shows aggressive end-of-life care for young cancer patients may be less effective

Study shows aggressive end-of-life care for young cancer patients may be less effective

Pembrolizumab drug shows significant clinical responses in metastatic head and neck cancer patients

Pembrolizumab drug shows significant clinical responses in metastatic head and neck cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.